Smith & Nephew SNATS Price to Sales Ratio 2010-2024 | SNN

Historical PS ratio values for Smith & Nephew SNATS (SNN) over the last 10 years. The current P/S ratio for Smith & Nephew SNATS as of January 31, 2025 is . For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
Smith & Nephew SNATS P/S Ratio Historical Data
Date Stock Price TTM Sales per Share Price to Sales Ratio
2025-01-31 25.38 inf
2020-06-30 34.09 0 0.00
2019-12-31 42.42 0 0.00
2019-06-30 38.18 0 0.00
2018-12-31 32.42 0 0.00
2018-06-30 32.30 0 0.00
2017-12-31 29.77 0 0.00
2017-06-30 29.44 0 0.00
2016-12-31 25.11 $2.78 9.03
2015-12-31 29.16 $5.35 5.45
2015-06-30 27.62 $7.92 3.49
2014-12-31 29.57 $10.32 2.87
2014-09-30 26.92 $10.15 2.65
2014-06-30 28.55 $9.85 2.90
2014-03-31 24.17 $9.65 2.50
2013-12-31 22.67 $9.62 2.36
2013-09-30 19.56 $7.01 2.79
2013-06-30 17.58 $7.14 2.46
2013-03-31 17.84 $6.90 2.58
2024-06-30 24.54 $6.83 3.59
2012-12-31 17.12 $9.25 1.85
2012-09-30 16.87 $9.33 1.81
2012-06-30 15.30 $9.53 1.61
2012-03-31 15.30 $9.64 1.59
2011-12-31 14.58 $7.23 2.02
2011-09-30 13.44 $7.12 1.89
2011-06-30 16.29 $7.19 2.27
2023-12-31 26.52 $6.83 3.88
2011-03-31 16.82 $8.99 1.87
2010-12-31 15.67 $8.87 1.77
2010-09-30 13.45 $8.88 1.51
2010-06-30 13.93 $8.90 1.57
2010-03-31 14.71 $6.74 2.18
2009-12-31 15.06 $6.58 2.29
2009-09-30 13.15 $6.11 2.15
2023-06-30 30.97 $4.03 7.68
2009-06-30 10.88 $4.03 2.70
2009-03-31 9.02 $1.94 4.65
2022-12-31 25.40 0 0.00
2022-06-30 26.04 0 0.00
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $11.065B $5.549B
Smith & Nephew is a global medical device company. The company markets clinically superior products, principally in orthopaedics, endoscopy and wound management to deliver cost-effective solutions, significant physicianadvantage and real patient benefits. A continuous process of supplying new and innovative products is supported by substantial R&D investment todeliver new levels of healing to patients throughout the world
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $221.767B 27.38
Boston Scientific (BSX) United States $151.377B 43.52
Stryker (SYK) United States $149.082B 32.08
EssilorLuxottica (ESLOY) France $125.055B 0.00
Medtronic (MDT) Ireland $117.214B 17.41
Lonza Group Ag (LZAGY) Switzerland $45.950B 0.00
Haleon (HLN) United Kingdom $43.139B 28.03
GE HealthCare Technologies (GEHC) United States $40.136B 20.82
ResMed (RMD) United States $37.119B 30.50
Terumo (TRUMY) Japan $28.886B 41.07
Koninklijke Philips (PHG) Netherlands $25.642B 19.63
Zimmer Biomet Holdings (ZBH) United States $22.107B 14.07
Insulet (PODD) United States $19.438B 77.40
Baxter (BAX) United States $16.737B 10.89
BellRing Brands (BRBR) United States $10.084B 40.57
Sunny Optical Technology (SNPTF) China $9.976B 0.00
Bio-Rad Laboratories (BIO) United States $9.966B 33.87
Demant (WILYY) Denmark $8.735B 0.00
Lantheus Holdings (LNTH) United States $6.433B 14.95
ICU Medical (ICUI) United States $4.121B 39.23
Prestige Consumer Healthcare (PBH) United States $3.893B 19.36
Envista Holdings (NVST) United States $3.678B 27.40
Haemonetics (HAE) United States $3.430B 16.74
Perrigo (PRGO) Ireland $3.366B 9.91
GN Store Nord (GNNDY) Denmark $3.027B 19.41
Shandong Weigao Medical Polymer (SHWGF) China $2.989B 0.00
QuidelOrtho (QDEL) United States $2.927B 18.84
Neogen (NEOG) United States $2.495B 28.75
LeMaitre Vascular (LMAT) United States $2.247B 54.60
AtriCure (ATRC) United States $2.067B 0.00
Green Thumb Industries (GTBIF) United States $1.464B 25.63
InMode (INMD) Israel $1.462B 8.79
AdaptHealth (AHCO) United States $1.430B 10.22
BioLife Solutions (BLFS) United States $1.313B 0.00
Maravai LifeSciences Holdings (MRVI) United States $1.270B 0.00
Owens & Minor (OMI) United States $1.150B 8.99
Evolus (EOLS) United States $0.922B 0.00
Phibro Animal Health (PAHC) United States $0.887B 15.64
CeriBell (CBLL) United States $0.833B 0.00
Curaleaf Holdings (CURLF) Canada $0.830B 0.00
Capricor Therapeutics (CAPR) United States $0.649B 0.00
VAREX IMAGING (VREX) United States $0.561B 24.73
Surmodics (SRDX) United States $0.511B 0.00
Omeros (OMER) United States $0.502B 0.00
Cresco Labs (CRLBF) United States $0.432B 0.00
Verano Holdings (VRNOF) United States $0.429B 0.00
Valneva SE (VALN) France $0.412B 0.00
ZimVie (ZIMV) United States $0.401B 33.77
Quanterix (QTRX) United States $0.370B 0.00
Cerus (CERS) United States $0.360B 0.00
Viemed Healthcare (VMD) United States $0.322B 30.67
Sanara MedTech (SMTI) United States $0.317B 0.00
Biote (BTMD) United States $0.309B 6.76
OraSure Technologies (OSUR) United States $0.291B 19.50
Canopy Growth (CGC) Canada $0.265B 0.00
Zynex (ZYXI) United States $0.263B 55.13
High Tide (HITI) Canada $0.239B 0.00
Sanuwave Health (SNWV) United States $0.233B 3.28
Utah Medical Products (UTMD) United States $0.208B 15.52
Aurora Cannabis (ACB) Canada $0.203B 0.00
Brainsway (BWAY) Israel $0.197B 104.70
MacroGenics (MGNX) United States $0.190B 0.00
Organigram Holdings (OGI) Canada $0.189B 0.00
TerrAscend (TSNDF) Canada $0.154B 0.00
TriSalus Life Sciences (TLSI) United States $0.149B 0.00
FitLife Brands (FTLF) United States $0.145B 18.27
Quipt Home Medical (QIPT) United States $0.135B 0.00
Jin Medical (ZJYL) China $0.125B 0.00
Fonar (FONR) United States $0.102B 11.54
Oramed Pharmaceuticals (ORMP) United States $0.091B 0.00
Veru (VERU) United States $0.089B 0.00
InterCure (INCR) Israel $0.077B 0.00
Exagen (XGN) United States $0.072B 0.00
INLIF (INLF) $0.071B 0.00
Rockwell Medical (RMTI) United States $0.066B 34.00
Jushi Holdings (JUSHF) United States $0.059B 0.00
Apyx Medical (APYX) United States $0.055B 0.00
Cytosorbents (CTSO) United States $0.055B 0.00
Modular Medical (MODD) United States $0.051B 0.00
Ayr Wellness (AYRWF) United States $0.051B 0.00
United-Guardian (UG) United States $0.050B 14.35
ImmuCell (ICCC) United States $0.048B 0.00
Safety Shot (SHOT) United States $0.031B 0.00
Nephros (NEPH) United States $0.018B 0.00
Allurion Technologies (ALUR) United States $0.015B 0.00
Innovative Eyewear (LUCY) United States $0.013B 0.00
Flora Growth (FLGC) United States $0.011B 0.00
Trinity Biotech (TRIB) Ireland $0.010B 0.00
Cellectar Biosciences (CLRB) United States $0.010B 0.00
NeuroMetrix (NURO) United States $0.009B 0.00
Meihua Medical Technologies (MHUA) China $0.008B 0.00
Agape ATP (ATPC) $0.005B 0.00
IM Cannabis (IMCC) Canada $0.005B 0.00
Senestech (SNES) United States $0.003B 0.00
Akanda (AKAN) United Kingdom $0.002B 0.00
GlucoTrack (GCTK) United States $0.002B 0.00
Sharps Technology (STSS) United States $0.001B 0.00
SNDL (SNDL) Canada $0.000B 0.00
InVivo Therapeutics Holdings (NVIVQ) United States $0.000B 0.00